BACKGROUND: Cardiogenic embolism (CE) and large-artery atherosclerosis embolism (LAA) are the two most common ischemic stroke (IS) subtypes. OBJECTIVE: In order to assist doctors in the precise diagnosis and treatment of patients, this study proposed an IS subtyping method combining convolutional neural networks (CNN) and radiomics. METHODS: Firstly, brain embolism regions were segmented from the computed tomography angiography (CTA) images, and radiomics features were extracted; Secondly, the extracted radiomics features were optimized with the L2 norm, and the feature selection was performed by combining random forest; then, the CNN Cap-UNet was built to extract the deep learning features of the last layer of the network; Finally, combining the selected radiomics features and deep learning features, 9 small-sample classifiers were trained respectively to build and select the optimal IS subtyping classification model. RESULTS: The experimental data include CTA images of 82 IS patients diagnosed and treated in Shanghai Sixth People’s Hospital. The AUC value and accuracy of the optimal subtyping model based on the Adaboost classifier are 0.9018 and 0.8929, respectively. CONCLUSION: The experimental results show that the proposed method can effectively predict the subtype of IS and has potential to assist doctors in making timely and accurate diagnoses of IS patients.
4 February 2025 in Frontiers in Aging Neuroscience
Objective: This study aim to leverage advanced machine learning techniques to develop and validate novel MRI imaging features and single nucleotide polymorphism (SNP) gene data fusion methodologies to enhance the early identification and diagnosis of Parkinson’s disease (PD).Methods: We leveraged a comprehensive dataset from the Parkinson’s Progression Markers Initiative (PPMI), which includes high-resolution neuroimaging data, genetic single-nucleotide polymorphism (SNP) profiles, and detailed clinical information from individuals with early-stage PD and healthy controls. Two multi-modal fusion strategies were used: feature-level fusion, where we employed a hybrid feature selection algorithm combining Fisher discriminant analysis, an ensemble Lasso (EnLasso) method, and partial least squares (PLS) regression to identify and integrate the most informative features from neuroimaging and genetic data; and decision-level fusion, where we developed an adaptive ensemble stacking (AE_Stacking) model to synergistically integrate the predictions from multiple base classifiers trained on individual modalities.Results: The AE_Stacking model achieving the highest average balanced accuracy of 95.36% and an area under the receiver operating characteristic curve (AUC) of 0.974, significantly outperforming feature-level fusion and single-modal models (p < 0.05). Furthermore, by analyzing the features selected across multiple iterations of our models, we identified stable brain region features [lh 6r (FD) and rh 46 (GI)] and key genetic markers (rs356181 and rs2736990 SNPs within the SNCA gene region; rs213202 SNP within the VPS52 gene region), highlighting their potential as reliable early diagnostic indicators for the disease.Conclusion: The AE_Stacking model, trained on MRI and genetic data, demonstrates potential in distinguishing individuals with PD. Our findings enhance understanding of the disease and advance us toward the goal of precision medicine for neurodegenerative disorder.
1 January 2022 in Contrast Media & Molecular Imaging
Objectives. We aimed to determine the difference between contrast‐enhanced spectral mammography (CESM) and contrast‐enhanced magnetic resonance imaging (CE‐MRI) in detecting multifocal and multicentric breast cancer (MMBC). Methods: This study was conducted among breast cancer patients between July 1, 2017, and May 30, 2021. The sensitivity, specificity, and accuracy of CESM and CE‐MRI in the diagnosis of MMBC were evaluated with pathological results as the gold standard. Results. A total of 188 lesions were detected in 54 patients with MMBC, including 177 breast cancer and 11 benign lesions. Based on CESM and CE‐MRI, 4 false‐positive cases and 3 false‐negative cases and 7 false‐positive cases and 1 false‐negative case, respectively, were found. The accuracy of CESM was higher than that of MRI (96.3% vs 95.7%), and the specificity was higher than that of MRI (63.6% vs 36.4%). There were no significant differences in the sensitivity, specificity, and accuracy for the detection of MMBC between CESM and CE‐MRI (p = 0.500; p = 0.250; p = 0.792). Conclusion. CESM is an effective method for the detection of MMBC, which is consistent with the sensitivity and accuracy of CE‐MRI.
6 September 2023 in Computer Methods and Programs in Biomedicine